GlassScriptPhysician profile
Jacob Michael Lurie
NPI 1407475247
$7,069.56
in general payments reported to CMS, 2019-2025
13 companies · $4,804 in 2025
The $4,804 reported for 2025 was more than what 93% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,266 · 2025: $4,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,835 · Travel and Lodging: $2,161 · Education: $74.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,834.65 |
| Travel and Lodging | $2,160.66 |
| Education | $74.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,029.47 | 2024-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $892.75 | 2024-2025 | Wavewriter Alpha Prime 16, Watchman Flx, Intracept |
| Globus Medical, INC. | $553.87 | 2025 | Senza |
| Saluda Medical Americas, INC. | $394.48 | 2024-2025 | Evoke |
| Spr Therapeutics, INC | $362.58 | 2024-2025 | Sprint Pns System |
| Biotronik Nro, INC. | $276.24 | 2024-2025 | Prospera |
| Painteq LLC | $153.12 | 2024 | Painteq |
| Nevro Corp. | $127.97 | 2024 | Senza |
| Curonix LLC | $122.79 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $50.28 | 2025 | |
| Bioventus LLC | $50.11 | 2025 | Durolane |
| Abbvie INC. | $28.95 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $26.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Lurie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.